- Home
- CTNM vs IH Comparison
CTNM vs IH Comparison
Compare CTNM & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- IH
- Stock Information
- Founded
- CTNM 2009
- IH 1996
- Country
- CTNM United States
- IH China
- Employees
- CTNM N/A
- IH 723
- Industry
- CTNM
- IH Other Consumer Services
- Sector
- CTNM
- IH Real Estate
- Exchange
- CTNM Nasdaq
- IH Nasdaq
- Market Cap
- CTNM 174.6M
- IH 146.3M
- IPO Year
- CTNM 2024
- IH 2020
- Fundamental
- Price
- CTNM $7.38
- IH $2.79
- Analyst Decision
- CTNM Strong Buy
- IH
- Analyst Count
- CTNM 4
- IH 0
- Target Price
- CTNM $22.50
- IH N/A
- AVG Volume (30 Days)
- CTNM 196.1K
- IH 32.0K
- Earning Date
- CTNM 08-05-2025
- IH 09-26-2025
- Dividend Yield
- CTNM N/A
- IH 2.99%
- EPS Growth
- CTNM N/A
- IH N/A
- EPS
- CTNM N/A
- IH 0.26
- Revenue
- CTNM N/A
- IH $123,701,096.00
- Revenue This Year
- CTNM N/A
- IH $39.02
- Revenue Next Year
- CTNM N/A
- IH N/A
- P/E Ratio
- CTNM N/A
- IH $10.84
- Revenue Growth
- CTNM N/A
- IH N/A
- 52 Week Low
- CTNM $3.35
- IH $1.47
- 52 Week High
- CTNM $20.55
- IH $3.60
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- IH 51.61
- Support Level
- CTNM N/A
- IH $2.50
- Resistance Level
- CTNM N/A
- IH $2.87
- Average True Range (ATR)
- CTNM 0.00
- IH 0.17
- MACD
- CTNM 0.00
- IH -0.04
- Stochastic Oscillator
- CTNM 0.00
- IH 50.52
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.